Florin Draica of Shionogi explains the 72-hour PEP window for ensitrelvir, breakthrough infection data, and which patients to ...
New York hepatitis B experts say screening gaps and weekly monitoring demands could limit who benefits from the first functional cure therapy.
CRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic ...
Obinutuzumab (Gazyva) led to complete remission of proteinuria in more patients than tacrolimus did, according to the FDA.
An oral SERD plus everolimus cut the risk of progression or death by 62% in ESR1-mutated advanced breast cancer.
Infectious disease and urology clinicians described unclear treatment goals, infusion limits, and access barriers for newer ...
Cardiologists and pharmacy leaders explained how team-based clinics and standardized paperwork are speeding obstructive HCM ...
New ACACIA-HCM analyses at HCMS 2026 add imaging and quality-of-life data as Cytokinetics readies an FDA filing in nonobstructive HCM.
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Prerna Mewawalla, MD, discusses fixed-duration bispecifics to limit infection risk and real-world data showing poor outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results